Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 82,031 | 152,310 | 166,799 | 205,999 | 12,359 |
| Gross Profit | 82,031 | 152,310 | 166,799 | 205,999 | 12,359 |
| Operating Expenses | 158,291 | 247,979 | 245,004 | 193,822 | 215,211 |
| Operating Income | -76,260 | -95,669 | -78,205 | 12,177 | -202,852 |
| Interest Expense | -10,095 | -15,195 | -16,591 | 420 | 1,921 |
| Other Income | 382 | -471 | 33,724 | -1,113 | 1,099 |
| Pre-tax Income | -65,783 | -80,945 | -27,890 | 10,644 | -203,674 |
| Income Tax | N/A | -4 | 1,835 | 1,295 | N/A |
| Net Income Continuous | -65,783 | -80,941 | -29,725 | 9,349 | -203,674 |
| Net Income | $-65,783 | $-80,941 | $-29,725 | $9,349 | $-203,674 |
| EPS Basic Total Ops | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 |
| EPS Basic Continuous Ops | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 |
| EPS Diluted Total Ops | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 |
| EPS Diluted Continuous Ops | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.00 | -1.99 | 0.35 | -7.74 |
| EBITDA(a) | $-73,235 | $-92,125 | $-75,248 | $13,704 | $-201,659 |